Logo do repositório
 

Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection

dc.contributor.authorFerreira, Lucas Souza [UNESP]
dc.contributor.authorGoncalves, Amanda Costa [UNESP]
dc.contributor.authorPortuondo, Deivys Leandro [UNESP]
dc.contributor.authorGeraldo Maia, Danielle Cardoso [UNESP]
dc.contributor.authorPolesi Placeres, Marisa Campos [UNESP]
dc.contributor.authorBatista-Duharte, Alexander [UNESP]
dc.contributor.authorCarlos, Iracilda Zeppone [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2015-10-21T20:55:33Z
dc.date.available2015-10-21T20:55:33Z
dc.date.issued2015-08-01
dc.description.abstractThe discovery of Th17 cells, along with many other Th cell subsets in the recent years, has expanded the Th1/Th2 paradigm that had persisted since its proposition by Mosmann in 1986. Defined by the characteristic expression of the transcription factor retinoic-related orphan receptor gamma t (ROR gamma t) and production of IL-17A (IL-17), Th17 cells are powerful inducers of tissue inflammation with a recognized role against extracellular bacteria and fungi. Despite this, the interest in their study came from the pivotal role they play in the development and maintenance of major chronic inflammatory conditions such as multiple sclerosis, rheumatoid arthritis and Crohn's disease, hence they have been the target of promising new anti-Th17 therapies. Accordingly, the identification of opportunistic pathogens whose clearance relies on the Th17 response is of huge prophylactic importance. As shown here for the first time, this applies to Sporothrix schenckii, a thermo-dimorphic fungus and the causative agent of sporotrichosis. Our results show that both Th17 and Th1/Th17 mixed cells are developed during the S. schenckii systemic mice infection, which also leads to augmented production of IL-17 and IL-22. Also, by using an antibody-mediated IL-23 depletion model, we further demonstrate that optimal fungal clearance, but not survival, depends on an intact Th17 response. (C) 2015 Elsevier GmbH. All rights reserved.en
dc.description.affiliationUniv Estadual Paulista UNESP, Araraquaras Sch Pharmaceut Sci, Dept Clin Anal, BR-14801902 Araraquara, SP, Brazil
dc.description.affiliationUnespUniv Estadual Paulista UNESP, Araraquaras Sch Pharmaceut Sci, Dept Clin Anal, BR-14801902 Araraquara, SP, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdFAPESP: 2012/24187-0
dc.format.extent985-992
dc.identifier.citationImmunobiology, v. 220, n. 8, p. 985-992, 2015.
dc.identifier.doi10.1016/j.imbio.2015.02.009
dc.identifier.issn0171-2985
dc.identifier.lattes1730146818754269
dc.identifier.urihttp://hdl.handle.net/11449/129361
dc.identifier.wosWOS:000356645400006
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofImmunobiology
dc.relation.ispartofjcr2.873
dc.relation.ispartofsjr1,100
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectSporothrix schenckiien
dc.subjectSporotrichosisen
dc.subjectTh17 cellen
dc.subjectTh17 responseen
dc.subjectIL-23 depletionen
dc.titleOptimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infectionen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isDepartmentOfPublicationa83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isDepartmentOfPublication.latestForDiscoverya83d26d6-5383-42e4-bb3c-2678a6ddc144
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes1730146818754269
unesp.author.orcid0000-0003-2282-7562[1]
unesp.author.orcid0000-0002-0084-3468[7]
unesp.author.orcid0000-0002-8343-8045[2]
unesp.author.orcid0000-0002-1875-0518[6]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentAnálises Clínicas - FCFpt

Arquivos